Industry Research Reports

Home > Reports > Service & Software > Global Immunohistochemistry (IHC) Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Immunohistochemistry (IHC) Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Service & Software

Published Date: 2026-08-13

Pages: 114 Pages

Report ld: 6989811

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

biaoTi KEY FINDINGS

Immunohistochemistry (IHC) Services enable biomarker detection and tissue-based molecular analysis

IHC services are widely applied in drug discovery and pathological research workflows

Pharmaceutical and biotechnology companies represent important customer groups for IHC services

North America and Europe remain major regions for advanced IHC service adoption

Multiplex staining and digital pathology technologies enhance IHC analytical capabilities

Immunohistochemistry (IHC) Services Market Size(US$)

CAGR 2026-2032

6.2%

Market Size,2032

USD 1,424

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 992 million

Market Forecast in 2032(Value)

US$ 1,424 million

CAGR

6.2%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Immunohistochemistry (IHC) Services market size was US$ 933 million in 2025 and is forecast to reach a readjusted size of US$ 1424 million by 2032 with a CAGR of 6.2% during the forecast period 2026-2032.

Immunohistochemistry (IHC) Services refer to specialized biological analysis services that use antibody-based detection technologies to identify and visualize specific proteins, biomarkers, and molecular targets within tissue samples. These services typically involve tissue preparation, fixation, embedding, sectioning, antigen retrieval, immunostaining, imaging analysis, and pathological interpretation to support biomedical research, drug discovery, clinical diagnostics, and translational medicine. This research focuses on commercial Immunohistochemistry (IHC) Services that provide customized tissue staining, biomarker evaluation, spatial protein expression analysis, and related analytical solutions for pharmaceutical companies, biotechnology organizations, research institutions, and healthcare applications.

biaoTi MARKET TRENDS

The development of Immunohistochemistry (IHC) Services is moving from conventional single-marker staining toward more advanced, quantitative, and multi-dimensional tissue analysis solutions. Increasing demand for precision medicine, biomarker-driven drug development, and translational research is driving service providers to integrate multiplex immunohistochemistry, automated staining platforms, digital pathology, and image analysis technologies. The industry is gradually shifting from standardized staining services toward customized analytical solutions capable of supporting complex biological interpretation and pharmaceutical research requirements.

MARKET SEGMENTATION

By Company

Charles River Laboratories
Labcorp Drug Development
IQVIA
ICON plc
Eurofins Scientific
Thermo Fisher Scientific
Bio-Techne
NeoGenomics Laboratories
HistoCyte Laboratories
Histowiz
WuXi AppTec
Provitro
NICHIREI BIOSCIENCES INC.
Samsung Biologics

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Biomarker Detection IHC Services
Protein Expression Analysis IHC Services
Tumor Tissue IHC Services
Normal Tissue IHC Services
Animal Model Tissue IHC Services

Segment by Application

Drug Discovery Research
Oncology Research
Clinical Biomarker Validation
Pathology Diagnosis
Toxicology Studies
Others

Segment by Category

Small-Scale IHC Service (<50 Slides)
Medium-Scale IHC Service (50–500 Slides)
Large-Scale IHC Service (>500 Slides)

biaoTi MARKET DYNAMICS

Drivers

Growing investment in oncology research, precision medicine, companion diagnostics, and biologics development is driving demand for Immunohistochemistry (IHC) Services. Pharmaceutical and biotechnology companies increasingly require reliable tissue-based biomarker analysis to support target validation, clinical research, and therapeutic development decisions.

Restraints

The Immunohistochemistry (IHC) Services market faces limitations related to technical complexity, variability in tissue samples, antibody performance differences, and the need for highly skilled interpretation. Maintaining consistent quality across different projects and ensuring standardized analytical workflows remain important challenges for service providers.

Opportunities

Expansion of personalized medicine, biomarker discovery, spatial biology research, and advanced cancer diagnostics creates new opportunities for IHC service providers. The combination of multiplex technologies, artificial intelligence-assisted image analysis, and digital pathology platforms is expected to broaden the application scope and improve analytical efficiency.

Challenges

The industry faces challenges related to regulatory requirements, technology standardization, data interpretation complexity, and increasing competition from emerging molecular analysis technologies. Service providers need to continuously improve technical capabilities and develop integrated solutions to maintain competitiveness in a rapidly evolving biomedical research environment.

biaoTi INDUSTRY CHAIN ANALYSIS

The industry chain of Immunohistochemistry (IHC) Services includes upstream antibody reagents, tissue processing materials, staining instruments, imaging equipment, and analytical software technologies. The midstream segment focuses on professional service providers delivering tissue preparation, immunostaining, biomarker analysis, digital imaging, and interpretation services. The downstream market consists of pharmaceutical companies, biotechnology companies, academic research institutions, hospitals, and diagnostic organizations applying IHC results in drug development, disease research, and clinical applications. The value creation process mainly depends on technical expertise, assay reliability, analytical accuracy, and the ability to provide customized solutions for specific research and diagnostic requirements.

biaoTi SEGMENT INSIGHTS

The Immunohistochemistry (IHC) Services market can be segmented by service type, technology approach, and application area. Standard immunohistochemistry remains a fundamental service category, while multiplex immunohistochemistry and advanced digital analysis solutions represent important growth directions due to increasing demand for deeper biological characterization. Oncology research represents one of the major application areas, supported by the importance of tissue biomarkers in cancer diagnosis, therapeutic selection, and drug development. Service providers with capabilities in customized assay development, quantitative image analysis, and integrated pathological interpretation are gaining stronger market opportunities.

biaoTi DOWNSTREAM MARKET OPPORTUNITIES

The downstream opportunities for Immunohistochemistry (IHC) Services are mainly concentrated in pharmaceutical research, biotechnology development, clinical diagnostics, academic studies, and translational medicine. Drug developers increasingly rely on IHC analysis for biomarker validation, mechanism studies, clinical trial support, and companion diagnostic development. Growing demand for precision healthcare and targeted therapies continues to expand the need for specialized tissue analysis services with higher accuracy and efficiency.

biaoTi REGIONAL INSIGHTS

North America represents a major market for Immunohistochemistry (IHC) Services due to its advanced biotechnology ecosystem, strong pharmaceutical research activities, and extensive clinical development infrastructure. Europe also maintains an important position supported by established biomedical research capabilities and pharmaceutical innovation activities. Asia Pacific is becoming an increasingly important growth region driven by expanding biotechnology investment, increasing research capacity, and rising demand for advanced biomedical testing services. Regional market differences mainly reflect variations in healthcare infrastructure, research funding, regulatory environment, and pharmaceutical development activity.

Fastest-Growing Region: Asia Pacific

XX.X
%
CAGR*
XXXX
US$ Million
XXXX
REGIONAL SHARE

BY TYPE,2021-2032(US $ MILLION)

Biomarker Detection IHC Services

Protein Expression Analysis IHC Services

Tumor Tissue IHC Services

Normal Tissue IHC Services

Animal Model Tissue IHC Services

BY APPLICATION，2021-2032(US $ MILLION）

Drug Discovery Research

Oncology Research

Clinical Biomarker Validation

Pathology Diagnosis

Toxicology Studies

Others

biaoTi COMPETITIVE LANDSCAPE ANALYSIS

The competitive landscape of Immunohistochemistry (IHC) Services is characterized by specialized life science service providers, contract research organizations, pathology service companies, and integrated biomedical analysis platforms. Competition is mainly based on technical expertise, assay development capability, analytical accuracy, turnaround efficiency, and the ability to support complex research projects. Companies with comprehensive service portfolios covering tissue processing, staining optimization, digital pathology, and data interpretation are better positioned to meet pharmaceutical and biotechnology customer requirements. Strategic integration of advanced imaging technologies and analytical platforms is becoming an important direction for enhancing service differentiation.

biaoTi REPORT SCOPE

The global Immunohistochemistry (IHC) Services market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.

biaoTi CHAPTER OUTLINE

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)

Chapter 2: Quantitative analysis of Immunohistochemistry (IHC) Services market size and growth potential at global, regional, and country levels

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities

Chapter 6: Regional revenue breakdown by company, type, application and customer

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies

Chapter 9: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Immunohistochemistry (IHC) Services value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032

1.2.2 Biomarker Detection IHC Services

1.2.3 Protein Expression Analysis IHC Services

1.2.4 Tumor Tissue IHC Services

1.2.5 Normal Tissue IHC Services

1.2.6 Animal Model Tissue IHC Services

1.3 Market by Application

1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032

1.3.2 Drug Discovery Research

1.3.3 Oncology Research

1.3.4 Clinical Biomarker Validation

1.3.5 Pathology Diagnosis

1.3.6 Toxicology Studies

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Immunohistochemistry (IHC) Services Market Perspective (2021-2032)

2.2 Global Market Size by Region: 2021 vs 2025 vs 2032

2.3 Global Immunohistochemistry (IHC) Services Market Share by Revenue, by Region (2021-2026)

2.4 Global Immunohistochemistry (IHC) Services Revenue Forecast by Region (2027-2032)

2.5 Major Regions and Emerging Markets Analysis

2.5.1 North America Immunohistochemistry (IHC) Services Market Size and Prospective (2021-2032)

2.5.2 Europe Immunohistochemistry (IHC) Services Market Size and Prospective (2021-2032)

2.5.3 China Immunohistochemistry (IHC) Services Market Size and Prospective (2021-2032)

2.5.4 Japan Immunohistochemistry (IHC) Services Market Size and Prospective (2021-2032)

2.5.5 Southeast Asia Immunohistochemistry (IHC) Services Market Size and Prospective (2021-2032)

2.5.6 India Immunohistochemistry (IHC) Services Market Size and Prospective (2021-2032)

2.5.7 South America Immunohistochemistry (IHC) Services Market Size and Prospective (2021-2032)

2.5.8 Middle East Immunohistochemistry (IHC) Services Market Size and Prospective (2021-2032)

3 Breakdown Data by Type

3.1 Global Immunohistochemistry (IHC) Services Historical Market Size by Type (2021-2026)

3.2 Global Immunohistochemistry (IHC) Services Forecasted Market Size by Type (2027-2032)

3.3 Representative Players for Different Types of Immunohistochemistry (IHC) Services

4 Breakdown Data by Application

4.1 Global Immunohistochemistry (IHC) Services Historical Market Size by Application (2021-2026)

4.2 Global Immunohistochemistry (IHC) Services Forecasted Market Size by Application (2027-2032)

4.3 New Sources of Growth in Immunohistochemistry (IHC) Services Applications

5 Competitive Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Immunohistochemistry (IHC) Services Players by Revenue (2021-2026)

5.1.2 Global Immunohistochemistry (IHC) Services Market Share by Revenue, by Players (2021-2026)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Immunohistochemistry (IHC) Services Revenue

5.4 Global Immunohistochemistry (IHC) Services Market Concentration Analysis

5.4.1 Global Immunohistochemistry (IHC) Services Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Immunohistochemistry (IHC) Services Revenue in 2025

5.5 Global Key Players of Immunohistochemistry (IHC) Services Head Offices and Areas Served

5.6 Global Key Players of Immunohistochemistry (IHC) Services, Product and Application

5.7 Global Key Players of Immunohistochemistry (IHC) Services, Date of Entry into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Immunohistochemistry (IHC) Services Revenue by Company (2021-2026)

6.1.2 North America Market Size by Type

6.1.2.1 North America Immunohistochemistry (IHC) Services Market Size by Type (2021-2026)

6.1.2.2 North America Immunohistochemistry (IHC) Services Market Share by Type (2021-2026)

6.1.3 North America Market Size by Application

6.1.3.1 North America Immunohistochemistry (IHC) Services Market Size by Application (2021-2026)

6.1.3.2 North America Immunohistochemistry (IHC) Services Market Share by Application (2021-2026)

6.1.4 North America Immunohistochemistry (IHC) Services Major Customers

6.1.5 North America Market Trends and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Immunohistochemistry (IHC) Services Revenue by Company (2021-2026)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Immunohistochemistry (IHC) Services Market Size by Type (2021-2026)

6.2.2.2 Europe Immunohistochemistry (IHC) Services Market Share by Type (2021-2026)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Immunohistochemistry (IHC) Services Market Size by Application (2021-2026)

6.2.3.2 Europe Immunohistochemistry (IHC) Services Market Share by Application (2021-2026)

6.2.4 Europe Immunohistochemistry (IHC) Services Major Customers

6.2.5 Europe Market Trends and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Immunohistochemistry (IHC) Services Revenue by Company (2021-2026)

6.3.2 China Market Size by Type

6.3.2.1 China Immunohistochemistry (IHC) Services Market Size by Type (2021-2026)

6.3.2.2 China Immunohistochemistry (IHC) Services Market Share by Type (2021-2026)

6.3.3 China Market Size by Application

6.3.3.1 China Immunohistochemistry (IHC) Services Market Size by Application (2021-2026)

6.3.3.2 China Immunohistochemistry (IHC) Services Market Share by Application (2021-2026)

6.3.4 China Immunohistochemistry (IHC) Services Major Customers

6.3.5 China Market Trends and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Immunohistochemistry (IHC) Services Revenue by Company (2021-2026)

6.4.2 Japan Market Size by Type

6.4.2.1 Japan Immunohistochemistry (IHC) Services Market Size by Type (2021-2026)

6.4.2.2 Japan Immunohistochemistry (IHC) Services Market Share by Type (2021-2026)

6.4.3 Japan Market Size by Application

6.4.3.1 Japan Immunohistochemistry (IHC) Services Market Size by Application (2021-2026)

6.4.3.2 Japan Immunohistochemistry (IHC) Services Market Share by Application (2021-2026)

6.4.4 Japan Immunohistochemistry (IHC) Services Major Customers

6.4.5 Japan Market Trends and Opportunities

6.5 Southeast Asia Market: Players, Segments, Downstream and Major Customers

6.5.1 Southeast Asia Immunohistochemistry (IHC) Services Revenue by Company (2021-2026)

6.5.2 Southeast Asia Market Size by Type

6.5.2.1 Southeast Asia Immunohistochemistry (IHC) Services Market Size by Type (2021-2026)

6.5.2.2 Southeast Asia Immunohistochemistry (IHC) Services Market Share by Type (2021-2026)

6.5.3 Southeast Asia Market Size by Application

6.5.3.1 Southeast Asia Immunohistochemistry (IHC) Services Market Size by Application (2021-2026)

6.5.3.2 Southeast Asia Immunohistochemistry (IHC) Services Market Share by Application (2021-2026)

6.5.4 Southeast Asia Immunohistochemistry (IHC) Services Major Customers

6.5.5 Southeast Asia Market Trends and Opportunities

6.6 India Market: Players, Segments, Downstream and Major Customers

6.6.1 India Immunohistochemistry (IHC) Services Revenue by Company (2021-2026)

6.6.2 India Market Size by Type

6.6.2.1 India Immunohistochemistry (IHC) Services Market Size by Type (2021-2026)

6.6.2.2 India Immunohistochemistry (IHC) Services Market Share by Type (2021-2026)

6.6.3 India Market Size by Application

6.6.3.1 India Immunohistochemistry (IHC) Services Market Size by Application (2021-2026)

6.6.3.2 India Immunohistochemistry (IHC) Services Market Share by Application (2021-2026)

6.6.4 India Immunohistochemistry (IHC) Services Major Customers

6.6.5 India Market Trends and Opportunities

7 Key Player Profiles

7.1 Charles River Laboratories

7.1.1 Charles River Laboratories Company Details

7.1.2 Charles River Laboratories Business Overview

7.1.3 Charles River Laboratories Immunohistochemistry (IHC) Services Introduction

7.1.4 Charles River Laboratories Revenue in Immunohistochemistry (IHC) Services Business (2021-2026)

7.1.5 Charles River Laboratories Recent Development

7.2 Labcorp Drug Development

7.2.1 Labcorp Drug Development Company Details

7.2.2 Labcorp Drug Development Business Overview

7.2.3 Labcorp Drug Development Immunohistochemistry (IHC) Services Introduction

7.2.4 Labcorp Drug Development Revenue in Immunohistochemistry (IHC) Services Business (2021-2026)

7.2.5 Labcorp Drug Development Recent Development

7.3 IQVIA

7.3.1 IQVIA Company Details

7.3.2 IQVIA Business Overview

7.3.3 IQVIA Immunohistochemistry (IHC) Services Introduction

7.3.4 IQVIA Revenue in Immunohistochemistry (IHC) Services Business (2021-2026)

7.3.5 IQVIA Recent Development

7.4 ICON plc

7.4.1 ICON plc Company Details

7.4.2 ICON plc Business Overview

7.4.3 ICON plc Immunohistochemistry (IHC) Services Introduction

7.4.4 ICON plc Revenue in Immunohistochemistry (IHC) Services Business (2021-2026)

7.4.5 ICON plc Recent Development

7.5 Eurofins Scientific

7.5.1 Eurofins Scientific Company Details

7.5.2 Eurofins Scientific Business Overview

7.5.3 Eurofins Scientific Immunohistochemistry (IHC) Services Introduction

7.5.4 Eurofins Scientific Revenue in Immunohistochemistry (IHC) Services Business (2021-2026)

7.5.5 Eurofins Scientific Recent Development

7.6 Thermo Fisher Scientific

7.6.1 Thermo Fisher Scientific Company Details

7.6.2 Thermo Fisher Scientific Business Overview

7.6.3 Thermo Fisher Scientific Immunohistochemistry (IHC) Services Introduction

7.6.4 Thermo Fisher Scientific Revenue in Immunohistochemistry (IHC) Services Business (2021-2026)

7.6.5 Thermo Fisher Scientific Recent Development

7.7 Bio-Techne

7.7.1 Bio-Techne Company Details

7.7.2 Bio-Techne Business Overview

7.7.3 Bio-Techne Immunohistochemistry (IHC) Services Introduction

7.7.4 Bio-Techne Revenue in Immunohistochemistry (IHC) Services Business (2021-2026)

7.7.5 Bio-Techne Recent Development

7.8 NeoGenomics Laboratories

7.8.1 NeoGenomics Laboratories Company Details

7.8.2 NeoGenomics Laboratories Business Overview

7.8.3 NeoGenomics Laboratories Immunohistochemistry (IHC) Services Introduction

7.8.4 NeoGenomics Laboratories Revenue in Immunohistochemistry (IHC) Services Business (2021-2026)

7.8.5 NeoGenomics Laboratories Recent Development

7.9 HistoCyte Laboratories

7.9.1 HistoCyte Laboratories Company Details

7.9.2 HistoCyte Laboratories Business Overview

7.9.3 HistoCyte Laboratories Immunohistochemistry (IHC) Services Introduction

7.9.4 HistoCyte Laboratories Revenue in Immunohistochemistry (IHC) Services Business (2021-2026)

7.9.5 HistoCyte Laboratories Recent Development

7.10 Histowiz

7.10.1 Histowiz Company Details

7.10.2 Histowiz Business Overview

7.10.3 Histowiz Immunohistochemistry (IHC) Services Introduction

7.10.4 Histowiz Revenue in Immunohistochemistry (IHC) Services Business (2021-2026)

7.10.5 Histowiz Recent Development

7.11 WuXi AppTec

7.11.1 WuXi AppTec Company Details

7.11.2 WuXi AppTec Business Overview

7.11.3 WuXi AppTec Immunohistochemistry (IHC) Services Introduction

7.11.4 WuXi AppTec Revenue in Immunohistochemistry (IHC) Services Business (2021-2026)

7.11.5 WuXi AppTec Recent Development

7.12 Provitro

7.12.1 Provitro Company Details

7.12.2 Provitro Business Overview

7.12.3 Provitro Immunohistochemistry (IHC) Services Introduction

7.12.4 Provitro Revenue in Immunohistochemistry (IHC) Services Business (2021-2026)

7.12.5 Provitro Recent Development

7.13 NICHIREI BIOSCIENCES INC.

7.13.1 NICHIREI BIOSCIENCES INC. Company Details

7.13.2 NICHIREI BIOSCIENCES INC. Business Overview

7.13.3 NICHIREI BIOSCIENCES INC. Immunohistochemistry (IHC) Services Introduction

7.13.4 NICHIREI BIOSCIENCES INC. Revenue in Immunohistochemistry (IHC) Services Business (2021-2026)

7.13.5 NICHIREI BIOSCIENCES INC. Recent Development

7.14 Samsung Biologics

7.14.1 Samsung Biologics Company Details

7.14.2 Samsung Biologics Business Overview

7.14.3 Samsung Biologics Immunohistochemistry (IHC) Services Introduction

7.14.4 Samsung Biologics Revenue in Immunohistochemistry (IHC) Services Business (2021-2026)

7.14.5 Samsung Biologics Recent Development

8 Immunohistochemistry (IHC) Services Market Dynamics

8.1 Immunohistochemistry (IHC) Services Industry Trends

8.2 Immunohistochemistry (IHC) Services Market Drivers

8.3 Immunohistochemistry (IHC) Services Market Challenges

8.4 Immunohistochemistry (IHC) Services Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Immunohistochemistry (IHC) Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Global Immunohistochemistry (IHC) Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 3. Global Market Immunohistochemistry (IHC) Services Market Size (US$ Million) by Region:2021 vs 2025 vs 2032

Table 4. Global Immunohistochemistry (IHC) Services Revenue (US$ Million) Market Share by Region (2021-2026)

Table 5. Global Immunohistochemistry (IHC) Services Revenue Share by Region (2021-2026)

Table 6. Global Immunohistochemistry (IHC) Services Revenue (US$ Million) Forecast by Region (2027-2032)

Table 7. Global Immunohistochemistry (IHC) Services Revenue Share Forecast by Region (2027-2032)

Table 8. Global Immunohistochemistry (IHC) Services Market Size by Type (2021-2026) & (US$ Million)

Table 9. Global Immunohistochemistry (IHC) Services Market Share by Revenue, by Type (2021-2026)

Table 10. Global Immunohistochemistry (IHC) Services Forecasted Market Size by Type (2027-2032) & (US$ Million)

Table 11. Global Immunohistochemistry (IHC) Services Market Share by Revenue, by Type (2027-2032)

Table 12. Representative Players of Each Type

Table 13. Global Immunohistochemistry (IHC) Services Market Size by Application (2021-2026) & (US$ Million)

Table 14. Global Immunohistochemistry (IHC) Services Market Share by Revenue, by Application (2021-2026)

Table 15. Global Immunohistochemistry (IHC) Services Forecasted Market Size by Application (2027-2032) & (US$ Million)

Table 16. Global Immunohistochemistry (IHC) Services Market Share by Revenue, by Application (2027-2032)

Table 17. New Sources of Growth in Immunohistochemistry (IHC) Services Applications

Table 18. Global Immunohistochemistry (IHC) Services Revenue by Players (2021-2026) & (US$ Million)

Table 19. Global Immunohistochemistry (IHC) Services Market Share by Players (2021-2026)

Table 20. Global Top Immunohistochemistry (IHC) Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunohistochemistry (IHC) Services as of 2025)

Table 21. Ranking of Global Top Immunohistochemistry (IHC) Services Companies by Revenue (US$ Million) in 2025

Table 22. Global 5 Largest Players Market Share by Immunohistochemistry (IHC) Services Revenue (CR5 and HHI) & (2021-2026)

Table 23. Global Key Players of Immunohistochemistry (IHC) Services, Headquarters and Area Served

Table 24. Global Key Players of Immunohistochemistry (IHC) Services, Product and Application

Table 25. Global Key Players of Immunohistochemistry (IHC) Services, Date of Entry into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Immunohistochemistry (IHC) Services Revenue by Company (2021-2026) & (US$ Million)

Table 28. North America Immunohistochemistry (IHC) Services Market Share by Revenue, by Company (2021-2026)

Table 29. North America Immunohistochemistry (IHC) Services Market Size by Type (2021-2026) & (US$ Million)

Table 30. North America Immunohistochemistry (IHC) Services Market Size by Application (2021-2026) & (US$ Million)

Table 31. Europe Immunohistochemistry (IHC) Services Revenue by Company (2021-2026) & (US$ Million)

Table 32. Europe Immunohistochemistry (IHC) Services Market Share by Revenue, by Company (2021-2026)

Table 33. Europe Immunohistochemistry (IHC) Services Market Size by Type (2021-2026) & (US$ Million)

Table 34. Europe Immunohistochemistry (IHC) Services Market Size by Application (2021-2026) & (US$ Million)

Table 35. China Immunohistochemistry (IHC) Services Revenue by Company (2021-2026) & (US$ Million)

Table 36. China Immunohistochemistry (IHC) Services Market Share by Revenue, by Company (2021-2026)

Table 37. China Immunohistochemistry (IHC) Services Market Size by Type (2021-2026) & (US$ Million)

Table 38. China Immunohistochemistry (IHC) Services Market Size by Application (2021-2026) & (US$ Million)

Table 39. Japan Immunohistochemistry (IHC) Services Revenue by Company (2021-2026) & (US$ Million)

Table 40. Japan Immunohistochemistry (IHC) Services Market Share by Revenue, by Company (2021-2026)

Table 41. Japan Immunohistochemistry (IHC) Services Market Size by Type (2021-2026) & (US$ Million)

Table 42. Japan Immunohistochemistry (IHC) Services Market Size by Application (2021-2026) & (US$ Million)

Table 43. Southeast Asia Immunohistochemistry (IHC) Services Revenue by Company (2021-2026) & (US$ Million)

Table 44. Southeast Asia Immunohistochemistry (IHC) Services Market Share by Revenue, by Company (2021-2026)

Table 45. Southeast Asia Immunohistochemistry (IHC) Services Market Size by Type (2021-2026) & (US$ Million)

Table 46. Southeast Asia Immunohistochemistry (IHC) Services Market Size by Application (2021-2026) & (US$ Million)

Table 47. India Immunohistochemistry (IHC) Services Revenue by Company (2021-2026) & (US$ Million)

Table 48. India Immunohistochemistry (IHC) Services Market Share by Revenue, by Company (2021-2026)

Table 49. India Immunohistochemistry (IHC) Services Market Size by Type (2021-2026) & (US$ Million)

Table 50. India Immunohistochemistry (IHC) Services Market Size by Application (2021-2026) & (US$ Million)

Table 51. Charles River Laboratories Company Details

Table 52. Charles River Laboratories Business Overview

Table 53. Charles River Laboratories Immunohistochemistry (IHC) Services Product

Table 54. Charles River Laboratories Revenue in Immunohistochemistry (IHC) Services Business (2021-2026) & (US$ Million)

Table 55. Charles River Laboratories Recent Development

Table 56. Labcorp Drug Development Company Details

Table 57. Labcorp Drug Development Business Overview

Table 58. Labcorp Drug Development Immunohistochemistry (IHC) Services Product

Table 59. Labcorp Drug Development Revenue in Immunohistochemistry (IHC) Services Business (2021-2026) & (US$ Million)

Table 60. Labcorp Drug Development Recent Development

Table 61. IQVIA Company Details

Table 62. IQVIA Business Overview

Table 63. IQVIA Immunohistochemistry (IHC) Services Product

Table 64. IQVIA Revenue in Immunohistochemistry (IHC) Services Business (2021-2026) & (US$ Million)

Table 65. IQVIA Recent Development

Table 66. ICON plc Company Details

Table 67. ICON plc Business Overview

Table 68. ICON plc Immunohistochemistry (IHC) Services Product

Table 69. ICON plc Revenue in Immunohistochemistry (IHC) Services Business (2021-2026) & (US$ Million)

Table 70. ICON plc Recent Development

Table 71. Eurofins Scientific Company Details

Table 72. Eurofins Scientific Business Overview

Table 73. Eurofins Scientific Immunohistochemistry (IHC) Services Product

Table 74. Eurofins Scientific Revenue in Immunohistochemistry (IHC) Services Business (2021-2026) & (US$ Million)

Table 75. Eurofins Scientific Recent Development

Table 76. Thermo Fisher Scientific Company Details

Table 77. Thermo Fisher Scientific Business Overview

Table 78. Thermo Fisher Scientific Immunohistochemistry (IHC) Services Product

Table 79. Thermo Fisher Scientific Revenue in Immunohistochemistry (IHC) Services Business (2021-2026) & (US$ Million)

Table 80. Thermo Fisher Scientific Recent Development

Table 81. Bio-Techne Company Details

Table 82. Bio-Techne Business Overview

Table 83. Bio-Techne Immunohistochemistry (IHC) Services Product

Table 84. Bio-Techne Revenue in Immunohistochemistry (IHC) Services Business (2021-2026) & (US$ Million)

Table 85. Bio-Techne Recent Development

Table 86. NeoGenomics Laboratories Company Details

Table 87. NeoGenomics Laboratories Business Overview

Table 88. NeoGenomics Laboratories Immunohistochemistry (IHC) Services Product

Table 89. NeoGenomics Laboratories Revenue in Immunohistochemistry (IHC) Services Business (2021-2026) & (US$ Million)

Table 90. NeoGenomics Laboratories Recent Development

Table 91. HistoCyte Laboratories Company Details

Table 92. HistoCyte Laboratories Business Overview

Table 93. HistoCyte Laboratories Immunohistochemistry (IHC) Services Product

Table 94. HistoCyte Laboratories Revenue in Immunohistochemistry (IHC) Services Business (2021-2026) & (US$ Million)

Table 95. HistoCyte Laboratories Recent Development

Table 96. Histowiz Company Details

Table 97. Histowiz Business Overview

Table 98. Histowiz Immunohistochemistry (IHC) Services Product

Table 99. Histowiz Revenue in Immunohistochemistry (IHC) Services Business (2021-2026) & (US$ Million)

Table 100. Histowiz Recent Development

Table 101. WuXi AppTec Company Details

Table 102. WuXi AppTec Business Overview

Table 103. WuXi AppTec Immunohistochemistry (IHC) Services Product

Table 104. WuXi AppTec Revenue in Immunohistochemistry (IHC) Services Business (2021-2026) & (US$ Million)

Table 105. WuXi AppTec Recent Development

Table 106. Provitro Company Details

Table 107. Provitro Business Overview

Table 108. Provitro Immunohistochemistry (IHC) Services Product

Table 109. Provitro Revenue in Immunohistochemistry (IHC) Services Business (2021-2026) & (US$ Million)

Table 110. Provitro Recent Development

Table 111. NICHIREI BIOSCIENCES INC. Company Details

Table 112. NICHIREI BIOSCIENCES INC. Business Overview

Table 113. NICHIREI BIOSCIENCES INC. Immunohistochemistry (IHC) Services Product

Table 114. NICHIREI BIOSCIENCES INC. Revenue in Immunohistochemistry (IHC) Services Business (2021-2026) & (US$ Million)

Table 115. NICHIREI BIOSCIENCES INC. Recent Development

Table 116. Samsung Biologics Company Details

Table 117. Samsung Biologics Business Overview

Table 118. Samsung Biologics Immunohistochemistry (IHC) Services Product

Table 119. Samsung Biologics Revenue in Immunohistochemistry (IHC) Services Business (2021-2026) & (US$ Million)

Table 120. Samsung Biologics Recent Development

Table 121. Immunohistochemistry (IHC) Services Market Trends

Table 122. Immunohistochemistry (IHC) Services Market Drivers

Table 123. Immunohistochemistry (IHC) Services Market Challenges

Table 124. Immunohistochemistry (IHC) Services Market Restraints

Table 125. Research Programs/Design for This Report

Table 126. Key Data Information from Secondary Sources

Table 127. Key Data Information from Primary Sources

List of Figures

Figure 1. Immunohistochemistry (IHC) Services Product Picture

Figure 2. Global Immunohistochemistry (IHC) Services Market Share by Type: 2025 vs 2032

Figure 3. Biomarker Detection IHC Services Features

Figure 4. Protein Expression Analysis IHC Services Features

Figure 5. Tumor Tissue IHC Services Features

Figure 6. Normal Tissue IHC Services Features

Figure 7. Animal Model Tissue IHC Services Features

Figure 8. Global Immunohistochemistry (IHC) Services Market Share by Application: 2025 vs 2032

Figure 9. Drug Discovery Research

Figure 10. Oncology Research

Figure 11. Clinical Biomarker Validation

Figure 12. Pathology Diagnosis

Figure 13. Toxicology Studies

Figure 14. Others

Figure 15. Immunohistochemistry (IHC) Services Report Years Considered

Figure 16. Global Immunohistochemistry (IHC) Services Market Size (US$ Million), Year-over-Year: 2021-2032

Figure 17. Global Immunohistochemistry (IHC) Services Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 18. Global Immunohistochemistry (IHC) Services Market Share by Revenue, by Region: 2021 vs 2025

Figure 19. North America Immunohistochemistry (IHC) Services Revenue (US$ Million) Growth Rate (2021-2032)

Figure 20. Europe Immunohistochemistry (IHC) Services Revenue (US$ Million) Growth Rate (2021-2032)

Figure 21. China Immunohistochemistry (IHC) Services Revenue (US$ Million) Growth Rate (2021-2032)

Figure 22. Japan Immunohistochemistry (IHC) Services Revenue (US$ Million) Growth Rate (2021-2032)

Figure 23. Southeast Asia Immunohistochemistry (IHC) Services Revenue (US$ Million) Growth Rate (2021-2032)

Figure 24. India Immunohistochemistry (IHC) Services Revenue (US$ Million) Growth Rate (2021-2032)

Figure 25. South America Immunohistochemistry (IHC) Services Revenue (US$ Million) Growth Rate (2021-2032)

Figure 26. Middle East Immunohistochemistry (IHC) Services Revenue (US$ Million) Growth Rate (2021-2032)

Figure 27. Global Immunohistochemistry (IHC) Services Market Share by Players in 2025

Figure 28. Global Top Immunohistochemistry (IHC) Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunohistochemistry (IHC) Services as of 2025)

Figure 29. The Top 10 and 5 Players Market Share by Immunohistochemistry (IHC) Services Revenue in 2025

Figure 30. North America Immunohistochemistry (IHC) Services Market Share by Type (2021-2026)

Figure 31. North America Immunohistochemistry (IHC) Services Market Share by Application (2021-2026)

Figure 32. Europe Immunohistochemistry (IHC) Services Market Share by Type (2021-2026)

Figure 33. Europe Immunohistochemistry (IHC) Services Market Share by Application (2021-2026)

Figure 34. China Immunohistochemistry (IHC) Services Market Share by Type (2021-2026)

Figure 35. China Immunohistochemistry (IHC) Services Market Share by Application (2021-2026)

Figure 36. Japan Immunohistochemistry (IHC) Services Market Share by Type (2021-2026)

Figure 37. Japan Immunohistochemistry (IHC) Services Market Share by Application (2021-2026)

Figure 38. Southeast Asia Immunohistochemistry (IHC) Services Market Share by Type (2021-2026)

Figure 39. Southeast Asia Immunohistochemistry (IHC) Services Market Share by Application (2021-2026)

Figure 40. India Immunohistochemistry (IHC) Services Market Share by Type (2021-2026)

Figure 41. India Immunohistochemistry (IHC) Services Market Share by Application (2021-2026)

Figure 42. Charles River Laboratories Revenue Growth Rate in Immunohistochemistry (IHC) Services Business (2021-2026)

Figure 43. Labcorp Drug Development Revenue Growth Rate in Immunohistochemistry (IHC) Services Business (2021-2026)

Figure 44. IQVIA Revenue Growth Rate in Immunohistochemistry (IHC) Services Business (2021-2026)

Figure 45. ICON plc Revenue Growth Rate in Immunohistochemistry (IHC) Services Business (2021-2026)

Figure 46. Eurofins Scientific Revenue Growth Rate in Immunohistochemistry (IHC) Services Business (2021-2026)

Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Immunohistochemistry (IHC) Services Business (2021-2026)

Figure 48. Bio-Techne Revenue Growth Rate in Immunohistochemistry (IHC) Services Business (2021-2026)

Figure 49. NeoGenomics Laboratories Revenue Growth Rate in Immunohistochemistry (IHC) Services Business (2021-2026)

Figure 50. HistoCyte Laboratories Revenue Growth Rate in Immunohistochemistry (IHC) Services Business (2021-2026)

Figure 51. Histowiz Revenue Growth Rate in Immunohistochemistry (IHC) Services Business (2021-2026)

Figure 52. WuXi AppTec Revenue Growth Rate in Immunohistochemistry (IHC) Services Business (2021-2026)

Figure 53. Provitro Revenue Growth Rate in Immunohistochemistry (IHC) Services Business (2021-2026)

Figure 54. NICHIREI BIOSCIENCES INC. Revenue Growth Rate in Immunohistochemistry (IHC) Services Business (2021-2026)

Figure 55. Samsung Biologics Revenue Growth Rate in Immunohistochemistry (IHC) Services Business (2021-2026)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Immunohistochemistry (IHC) Services in 2032? zhanKai

The global market size of Immunohistochemistry (IHC) Services in 2032 was 1424 Million USD.

Which companies rank high in the global Immunohistochemistry (IHC) Services market? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Immunohistochemistry (IHC) Services in 2026? shouQi

What is the annual compound growth rate of the global Immunohistochemistry (IHC) Services market size from 2026 to 2032? shouQi

Related Reports

Global Immunohistochemistry (IHC) Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Immunohistochemistry (IHC) Services market is projected to grow from US$ 933 million in 2025 to US$ 1424 million by 2032, at a CAGR of 6.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-13
Pages: 145
USD 4900.00
(Single User License)
Immunohistochemistry (IHC) Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Immunohistochemistry (IHC) Services was estimated to be worth US$ 933 million in 2025 and is projected to reach US$ 1424 million, growing at a CAGR of 6.2% from 2026 to 2032.
Published Date: 2026-08-13
Pages: 114
USD 3950.00
(Single User License)
Global Immunohistochemistry (IHC) Services Market Research Report 2026
The global Immunohistochemistry (IHC) Services market was valued at US$ 933 million in 2025 and is anticipated to reach US$ 1424 million by 2032, at a CAGR of 6.2% from 2026 to 2032.
Published Date: 2026-08-13
Pages: 114
USD 2900.00
(Single User License)

Global Immunohistochemistry (IHC) Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Immunohistochemistry (IHC) Services market is projected to grow from US$ 933 million in 2025 to US$ 1424 million by 2032, at a CAGR of 6.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-13
Pages: 145
USD 4900.00 (Single User License)
Immunohistochemistry (IHC) Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Immunohistochemistry (IHC) Services was estimated to be worth US$ 933 million in 2025 and is projected to reach US$ 1424 million, growing at a CAGR of 6.2% from 2026 to 2032.
Published: 2026-08-13
Pages: 114
USD 3950.00 (Single User License)
Global Immunohistochemistry (IHC) Services Market Research Report 2026
The global Immunohistochemistry (IHC) Services market was valued at US$ 933 million in 2025 and is anticipated to reach US$ 1424 million by 2032, at a CAGR of 6.2% from 2026 to 2032.
Published: 2026-08-13
Pages: 114
USD 2900.00 (Single User License)